Elevance Health Inc.
General ticker "ELV" information:
- Sector: Health Care
- Industry: Medical - Healthcare Plans
- Capitalization: $77.0B (TTM average)
Elevance Health Inc. follows the US Stock Market performance with the rate: 48.5%.
Estimated limits based on current volatility of 1.5%: low 413.78$, high 426.54$
Factors to consider:
- Company included in S&P500 list
- Company pays dividends (quarterly): last record date 2026-06-10, amount 1.72$ (Y1.65%)
- Total employees count: 97100 (-6.8%) as of 2025
- Top business risk factors: Healthcare cost prediction, Regulatory and compliance, Cybersecurity threats, Litigation risks, Market competition
- Price in estimated range
- Earnings for 6 months up through Q2 are close to our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2025-12-31 to 2027-12-31
- 2025-12-31 to 2026-12-31 estimated range: [269.01$, 420.18$]
- 2026-12-31 to 2027-12-31 estimated range: [292.60$, 448.78$]
Financial Metrics affecting the ELV estimates:
- Negative: with PPE of 11.5 at the end of fiscal year the price was high
- Positive: 0.56 < Operating profit margin, % of 3.64
- Negative: Investing cash flow per share per price, % of -1.75 <= -1.23
- Positive: 34.41 < Shareholder equity ratio, % of 36.12 <= 42.26
- Positive: 0.59 < Industry operating profit margin (median), % of 1.57
- Positive: 4.90 < Operating cash flow per share per price, % of 5.58
- Negative: Industry operating cash flow per share per price (median), % of 3.62 <= 3.66
- Positive: Inventory ratio change, % of 0.10 <= 0.41
- Negative: 1.42 < Interest expense per share per price, % of 1.82
- Positive: Industry inventory ratio change (median), % of 0.22 <= 0.47
Short-term ELV quotes
Relationship graph
Long-term ELV plot with estimates
Financial data
| YTD | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|
| Operating Revenue | $171,340.00MM | $176,810.00MM | $197,723.00MM |
| Operating Expenses | $162,595.00MM | $167,922.00MM | $190,524.00MM |
| Operating Income | $8,745.00MM | $8,888.00MM | $7,199.00MM |
| Non-Operating Income | $-1,030.00MM | $-984.00MM | $-489.00MM |
| Interest Expense | $1,030.00MM | $1,185.00MM | $1,402.00MM |
| Income(Loss) | $7,715.00MM | $7,904.00MM | $6,710.00MM |
| Taxes | $1,724.00MM | $1,933.00MM | $1,049.00MM |
| Net Income(Loss)* | $5,987.00MM | $5,980.00MM | $5,662.00MM |
| Stockholders Equity | $39,306.00MM | $41,315.00MM | $43,882.00MM |
| Assets | $108,928.00MM | $116,889.00MM | $121,494.00MM |
| Operating Cash Flow | $8,061.00MM | $5,808.00MM | $4,290.00MM |
| Capital expenditure | $1,296.00MM | $1,256.00MM | $1,116.00MM |
| Investing Cash Flow | $-5,572.00MM | $-5,167.00MM | $-1,344.00MM |
| Financing Cash Flow | $-3,349.00MM | $1,193.00MM | $-1,738.00MM |
| Earnings Per Share** | $25.69 | $25.68 | $25.53 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.